- News Releases
-
- May 12, 2021 (PDF/2,290KB)Finances
- Investors Meeting Presentation for FY2020 (Year ended March 31, 2021) and Revision of Mid-term Business Plan 2022
-
- May 12, 2021 (PDF/425KB)Finances
- Supplementary Financial Data (IFRS) for the Year Ended March 31, 2021
-
- May 12, 2021 (PDF/558KB)Finances
- Summary of Consolidated Financial Results for the Year Ended March 31, 2021 [IFRS]
-
- May 12, 2021 (PDF/1,018KB)Finances
- Sumitomo Dainippon Pharma Announces Revised Mid-term Business Plan 2022 (FY2018-FY2022)
-
- May 12, 2021 (PDF/140KB)Corporate
- Notice of Change of Trade Name and Partial Amendment to Articles of Incorporation
Other Notices
-
- Mar. 25, 2021Corporate (PDF/129KB)
- Sumitomo Dainippon Pharma Announces the Launch of Website Dedicated to Frontier Business
-
- Nov. 20, 2020Others
- Posted Factbook 2020 ver.2
-
- Sep. 30, 2020Others
- Posted Integrated Report 2020
IR Library
-
Continuing to challenge ourselves to support a healthy future for people
-
Aiming to create innovative pharmaceutical products
-
Thinking BEYOND medication
-
Targeting sustainable growth
-
Leading our global expansion